MYC and plasma cell myeloma: We demonstrated that HDACi mediates c-Myc acetylation on the CD26 promoter of myeloma cells, which leads to activation of the promoter and initiation of CD26 transcription in myeloma cells as one of mechanisms for the induction of CD26 in myeloma cells.